Wird geladen...
Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis
BACKGROUND: Published lead time estimates in breast cancer screening vary from 1 to 7 years and the percentages of overdiagnosis vary from 0 to 75%. The differences are usually explained as random variations. We study how much can be explained by using different definitions and methods. METHODS: We...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Nature Publishing Group
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3790152/ https://ncbi.nlm.nih.gov/pubmed/23963144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.427 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|